Existing oncology therapeutics are either so specific they can target only part of a tumor, or so generalized they kill healthy tissue.

Scientists found that nearly every cancer harbors its own distinct community of microbes – tiny passengers that can influence ...

Nearly 1,300 Georgetown University students, faculty and volunteers biked through the Washington, D.C. and Maryland hills Oct. 25 for BellRinger, an annual fundraiser supporting cancer research.

Researchers at the University of São Paulo have discovered a molecule in arachnid venom that behaves like a commonly used chemotherapy drug for treating the disease, with preliminary findings ...

Rates of colorectal cancer are rising, especially for people younger than 50. But it's hard to raise awareness for a cancer that a lot of us find hard to talk about.

The influential oncology guidelines body revised guidelines with a nod to the FDA's explicit recommendation for testing in Xeloda's label.

The investigational oral KRAS G12D inhibitor VS-7375 (GFH375) has shown a promising early safety profile and preliminary antitumor activity in pretreated patients with advanced solid tumors harboring ...

Q3 2025 Earnings Call Transcript October 30, 2025 Operator: Good afternoon. Thank you for attending the Guardant Health Q3 ...

Phase 3 Trial Design: The FDA agreed with Adagene’s proposed standard-of-care (SOC) control arm for the Phase 3 clinical trial and confirmed that a muzastotug monotherapy arm was also not required.

Once I’ve finished the marathon, gotten my medal, it gives me two or three months of just that runner’s high,” Liz Healy told ...

Taken together with previous observational, genomic, and early trial data, our findings support the integration of aspirin into clinical practice for a molecularly defined subgroup of patients with ...